Literature DB >> 2912874

Immunohistochemical distinction of malignant mesothelioma from pulmonary adenocarcinoma with anti-surfactant apoprotein, anti-Lewisa, and anti-Tn antibodies.

M Noguchi1, T Nakajima, S Hirohashi, T Akiba, Y Shimosato.   

Abstract

Nine cases of malignant mesothelioma of pure epithelial and biphasic types (five pleural, three peritoneal, and one pericardial mesotheliomas), seven cases of benign adenomatoid tumor of the uterus, and 21 cases of peripheral pulmonary adenocarcinoma of non-mucus-producing type were examined immunohistochemically for expression of keratin, vimentin, carcinoembryonic antigen (CEA), surfactant apoprotein, Lewis blood group antigens, and Tn antigen. The majority (78%) of the malignant mesotheliomas expressed keratin, but CEA and surfactant apoprotein were not detected in any mesotheliomas. On the other hand, pulmonary adenocarcinomas expressed not only keratin (100%), but also CEA (62%) and surfactant apoprotein (62%). The expression of Lewisa blood group antigen and Tn antigen was detected in 76% and 62% of the pulmonary adenocarcinomas, respectively, but only one mesothelioma was stained for Lewisa antigen. This study reveals that the majority of malignant mesotheliomas can be distinguished from pulmonary adenocarcinomas by immunohistochemcial staining for CEA, surfactant apoprotein, Lewisa antigen, and Tn antigen. Immunohistochemically, adenomatoid tumors behaved similarly to malignant mesotheliomas.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2912874     DOI: 10.1016/0046-8177(89)90202-5

Source DB:  PubMed          Journal:  Hum Pathol        ISSN: 0046-8177            Impact factor:   3.466


  6 in total

Review 1.  The classification of pericardial disease in the age of modern medicine.

Authors:  Bernhard Maisch; Arsen D Ristić
Journal:  Curr Cardiol Rep       Date:  2002-01       Impact factor: 2.931

2.  Comparison of six immunohistochemical markers for the histologic diagnosis of neoplasia in Barrett's esophagus.

Authors:  Andreas Weimann; Anja Rieger; Mathias Zimmermann; Monica Gross; Peter Hoffmann; Hortense Slevogt; Lars Morawietz
Journal:  Virchows Arch       Date:  2010-09-16       Impact factor: 4.064

3.  Diagnostic tools for differentiating between pleural mesothelioma and lung adenocarcinoma in paraffin embedded tissue. Part I: Immunohistochemical findings.

Authors:  H Moch; M Oberholzer; P Dalquen; W Wegmann; F Gudat
Journal:  Virchows Arch A Pathol Anat Histopathol       Date:  1993

4.  ME1. A monoclonal antibody that distinguishes epithelial-type malignant mesothelioma from pulmonary adenocarcinoma and extrapulmonary malignancies.

Authors:  C J O'Hara; J M Corson; G S Pinkus; R A Stahel
Journal:  Am J Pathol       Date:  1990-02       Impact factor: 4.307

Review 5.  Primary malignant mesothelioma of the pericardium. Case report and literature review.

Authors:  R Thomason; W Schlegel; M Lucca; S Cummings; S Lee
Journal:  Tex Heart Inst J       Date:  1994

Review 6.  Protein glycosylation in cancers and its potential therapeutic applications in neuroblastoma.

Authors:  Wan-Ling Ho; Wen-Ming Hsu; Min-Chuan Huang; Kenji Kadomatsu; Akira Nakagawara
Journal:  J Hematol Oncol       Date:  2016-09-29       Impact factor: 17.388

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.